( June 3, 2026, 1:03 PM EDT) -- WASHINGTON, D.C. — The federal government’s response to a petition for a writ of certiorari on whether state unfair competition laws are preempted by federal law in cases accusing compounding pharmacies of marketing drugs without premarket approval by the U.S. Food and Drug Administration “underscores the need for this Court’s review,” a compounding pharmacy tells the U.S. Supreme Court in a June 2 supplemental brief....